食品科学 ›› 2017, Vol. 38 ›› Issue (14): 49-57.doi: 10.7506/spkx1002-6630-201714008

• 生物工程 • 上一篇    下一篇

瑞士乳杆菌MG9-2微胶囊的制备工艺优化及其性能分析

宋娇娇,包秋华,王亚利,尚一娜,霍麒文,张晓宁,陈境,李明慧,王俊国   

  1. (内蒙古农业大学 乳品生物技术与工程教育部重点实验室,农业部奶制品加工重点实验室,内蒙古?呼和浩特 010018)
  • 出版日期:2017-07-25 发布日期:2017-09-06
  • 基金资助:
    国家自然科学基金地区科学基金项目(31160315;31660456);国家自然科学基金青年科学基金项目(31301516);内蒙古自然科学基金项目(2015MS0306);中国科学院西部之光人才培养项目

Optimization of Preparation Process and Properties of Microcapsules Containing Lactobacillus helveticus MG9-2

SONG Jiaojiao, BAO Qiuhua, WANG Yali, SHANG Yina, HUO Qiwen, ZHANG Xiaoning, CHEN Jing, LI Minghui, WANG Junguo   

  1. (Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Key Laboratory of Dairy Processing, Ministry of Agriculture, Inner Mongolia Agricultural University, Hohhot 010018, China)
  • Online:2017-07-25 Published:2017-09-06

摘要: 以乳蛋白为壁材,利用内源乳化法制备瑞士乳杆菌MG9-2微胶囊,对其进行工艺优化,并比较添加不同钙盐作为交联剂(CaCl2和CaCO3)对微胶囊性能的影响。结果显示制备瑞士乳杆菌MG9-2微胶囊的最佳工艺参数为:乳化搅拌速率800?r/min、水油比1∶10、脱脂乳质量浓度0.35?g/mL、钙盐浓度1.5?mol/L。在此条件下以CaCO3、CaCl2为交联剂制得MG9-2微胶囊的包埋率分别为(78.4±3.6)%和(75.7±4.9)%,无显著性差异。但与CaCl2为交联剂制得的MG9-2微胶囊相比,CaCO3制得的微胶囊粒径较小,表面较致密、形状较规则、分散性较好,且具有较好的肠液释放性和耐胃酸性。结果表明,以CaCO3为交联剂在室温制备瑞士乳杆菌MG9-2微胶囊的工艺简单且性能较好。

关键词: 微胶囊, 瑞士乳杆菌MG9-2, CaCl2, CaCO3

Abstract: Lactobacillus helveticus MG9-2 was microencapsulated with milk protein as wall material by means of emulsification/internal gelation. The preparation process was optimized, and the effect of different calcium salts (CaCO3 and CaCl2) as crosslinking?agents on microencapsulation efficiency was investigated. The results showed that the optimal process parameters were as follows: stirring speed, 800 r/min; water-to-oil ratio, 1:10; concentration of skim milk, 0.35 g/mL; and concentration of calcium salt, 1.5 mol/L. Under these conditions, the microencapsulation efficiency (ME) of viable cells with CaCO3 and CaCl2 were (78.4 ± 3.6)% and (75.7 ± 4.9)%, respectively, with no significant difference being observed between them. Microcapsules prepared with CaCO3 were smaller in size than those prepared with CaCO3, exhibiting a more compact surface, and a more regular spherical shape and a narrower size distribution and displaying a better resistance to intestinal release and gastric acid. The findings demonstrated that microcapsules with improved properties could be prepared more simply using CaCO3 as crosslinking?agent than CaCl2.

Key words: microencapsulation, Lactobacillus helveticus MG9-2, CaCl2, CaCO3

中图分类号: